Ernest Impex India | Exporting Celnalid 25 mg to Thailand Medical Centers

Celnalid 25 mg Capsule Advanced Lenalidomide Oncology Therapy

Are you searching for a reliable Celnalid 25 mg Capsule exporter from India? Ernest Impex, under the Group of Ernest Pharmaceutical Pvt. Ltd., is a global leader in providing high-potency oncology treatments. We specialize in secure pharmaceutical supply and cold-chain logistics to Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica).

Extensive Product Profile: Understanding Celnalid 25 mg

Celnalid 25 mg Capsule, manufactured by Celon Laboratories Ltd., contains the active ingredient Lenalidomide. This 25 mg strength is a critical therapeutic dosage for patients battling aggressive hematological malignancies. As an immunomodulatory drug (IMiD), it is engineered to target cancer cells through multiple biological pathways, offering a sophisticated approach to blood cancer management.

1. Clinical Indications & Usage

Celnalid 25 mg is primarily indicated for the following:

• Multiple Myeloma (MM): Often used in combination with dexamethasone for both newly diagnosed patients and those who have received at least one prior therapy.

• Mantle Cell Lymphoma (MCL): Prescribed for patients whose disease has relapsed or progressed after at least two prior therapies, including one with bortezomib.

• Follicular Lymphoma (FL): Used in combination with a rituximab product for previously treated patients.

• Myelodysplastic Syndromes (MDS): Indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

2. Mechanism of Action: The Science of Immunomodulation

Lenalidomide operates via a complex, multi-faceted mechanism of action:

• Direct Anti-Tumor Activity: It binds to the protein Cereblon, part of the CRL4CRBN E3 ubiquitin ligase complex. This leads to the degradation of specific transcription factors (Ikaros and Aiolos), which are essential for the survival of malignant B-cells.

• Anti-Angiogenic Properties: It inhibits the formation of new blood vessels (angiogenesis) that tumors need to grow, effectively "starving" the cancer cells of oxygen and nutrients.

• Immune System Enhancement: It stimulates the proliferation and activation of T-cells and Natural Killer (NK) cells, empowering the body's own defenses to identify and destroy cancerous cells.

• Cytokine Regulation: It inhibits the production of pro-inflammatory cytokines like TNF-$\alpha$ and IL-6, which otherwise support cancer growth in the bone marrow microenvironment.

3. Administration and Dosing Guide

• Typical Cycle: For Multiple Myeloma, the standard dose is 25 mg taken once daily for the first 21 days of a 28-day cycle.

• Method: The capsule must be swallowed whole with water. Do not break, chew, or open the capsule.

• Consistency: Can be taken with or without food, preferably at the same time each day.

Potential Side Effects of Celnalid 25 mg

Patients undergoing treatment with Celnalid 25 mg should be closely monitored by a healthcare professional. Common and serious side effects include:

• Hematologic Effects: Significant decrease in white blood cells (neutropenia) and platelets (thrombocytopenia), increasing the risk of infection and bleeding.

• Venous Thromboembolism: Increased risk of deep vein thrombosis (DVT) and pulmonary embolism (PE).

• Gastrointestinal Issues: Diarrhea, constipation, nausea, and abdominal pain.

• Systemic Symptoms: Fatigue, fever, muscle cramps, and back pain.

• Teratogenicity: Serious Warning: Lenalidomide can cause severe life-threatening birth defects or death to an unborn baby. Strict adherence to pregnancy prevention programs is mandatory.

Storage, Handling, and Stability Protocols

• Temperature: Store at controlled room temperature between 15°C to 30°C.

• Environment: Keep the medication in a dry place, away from direct sunlight and moisture.

• Safety: Always store in the original packaging. Keep out of the reach of children and pets.

• Disposal: Unused capsules should be returned to a pharmacy or healthcare provider to ensure safe disposal according to hazardous medical waste regulations.